Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis.
作者信息
Mehta Gautam U, Panackal Anil A, Murayi Roger, Bennett John E, Williamson Peter R, Chittiboina Prashant
机构信息
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
出版信息
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):219-220. doi: 10.1136/jnnp-2017-315830. Epub 2017 May 26.
Abstract
摘要
相似文献
1
Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis.
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):219-220. doi: 10.1136/jnnp-2017-315830. Epub 2017 May 26.
2
Evaluation of ventriculoperitoneal shunt in the treatment of intracranial hypertension in the patients with cryptococcal meningitis: a report of 12 cases.
Clin Neurol Neurosurg. 2014 Sep;124:156-60. doi: 10.1016/j.clineuro.2014.07.001. Epub 2014 Jul 10.
3
Ventriculoperitoneal shunts for treating increased intracranial pressure in cryptococcal meningitis with or without ventriculomegaly.
Rev Soc Bras Med Trop. 2014 Jul;47(4):524-7. doi: 10.1590/0037-8682-0176-2013.
4
Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis.
BMC Neurol. 2018 May 1;18(1):58. doi: 10.1186/s12883-018-1053-0.
5
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis.
Surg Neurol. 2005 Jun;63(6):529-31; discussion 531-2. doi: 10.1016/j.surneu.2004.08.069.
6
The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus.
Biosci Trends. 2014 Dec;8(6):327-32. doi: 10.5582/bst.2014.01070.
7
Ventriculoperitoneal shunt for intracranial hypertension in cryptococcal meningitis without hydrocephalus.
J Clin Neurosci. 2012 Aug;19(8):1175-6. doi: 10.1016/j.jocn.2012.01.008. Epub 2012 Jun 2.
8
Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus.
Clin Infect Dis. 2002 Jun 15;34(12):E64-8. doi: 10.1086/340525. Epub 2002 May 17.
9
Ventriculoperitoneal shunt in the treatment of cryptococcal meningitis with intracranial hypertension.
J Infect Dev Ctries. 2024 Dec 30;18(12):1949-1956. doi: 10.3855/jidc.19341.
10
A comparison of the surgical outcomes of ventriculoperitoneal versus lumbar peritoneal shunts in the management of intracranial hypertension secondary to cryptococcal meningitis in HIV infected adult patients.
Clin Neurol Neurosurg. 2024 Mar;238:108184. doi: 10.1016/j.clineuro.2024.108184. Epub 2024 Feb 19.
引用本文的文献
1
Cryptococcal Meningoencephalitis in Phenotypically Normal Patients.
Pathogens. 2023 Oct 31;12(11):1303. doi: 10.3390/pathogens12111303.
2
Persistent neurological symptoms and elevated intracranial pressures in a previously healthy host with cryptococcal meningitis.
BMC Infect Dis. 2023 Jun 14;23(1):407. doi: 10.1186/s12879-023-08349-y.
3
Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome.
Front Neurol. 2022 Dec 1;13:994396. doi: 10.3389/fneur.2022.994396. eCollection 2022.
4
Case report: a special case of cryptococcal infection-related inflammatory syndrome in a non-HIV infected and non-transplant patient.
BMC Neurol. 2022 Jul 6;22(1):247. doi: 10.1186/s12883-022-02773-4.
5
Post-Infectious Inflammatory Response Syndrome in an HIV-Negative Immunocompetent Elderly Patient With Cryptococcal Meningitis: A Case Report and Literature Review.
Front Immunol. 2022 Feb 23;13:823021. doi: 10.3389/fimmu.2022.823021. eCollection 2022.
6
Case Report: Paradoxical Inflammatory Response Syndrome in a Previously Healthy, HIV-Negative, Pediatric Patient With Meningitis.
Front Pediatr. 2021 Aug 25;9:703895. doi: 10.3389/fped.2021.703895. eCollection 2021.
7
Cryptococcal Meningitis and Post-Infectious Inflammatory Response Syndrome in a Patient With X-Linked Hyper IgM Syndrome: A Case Report and Review of the Literature.
Front Immunol. 2021 Jul 15;12:708837. doi: 10.3389/fimmu.2021.708837. eCollection 2021.
8
Clinical Aspects of Immune Damage in Cryptococcosis.
Curr Fungal Infect Rep. 2019 Sep;13(3):99-108. doi: 10.1007/s12281-019-00345-7. Epub 2019 Jul 22.
9
HIV-Negative Cryptococcal Meningoencephalitis Results in a Persistent Frontal-Subcortical Syndrome.
Sci Rep. 2019 Dec 5;9(1):18442. doi: 10.1038/s41598-019-54876-7.
10
Immunomodulatory Role of Capsular Polysaccharides Constituents of .
Front Med (Lausanne). 2019 Jun 19;6:129. doi: 10.3389/fmed.2019.00129. eCollection 2019.
本文引用的文献
1
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis.
N Engl J Med. 2016 Feb 11;374(6):542-54. doi: 10.1056/NEJMoa1509024.
2
Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis.
PLoS Pathog. 2015 May 28;11(5):e1004884. doi: 10.1371/journal.ppat.1004884. eCollection 2015 May.
3
A retrospective study of contributing factors for prognosis and survival length of cryptococcal meningoencephalitis in Southern part of China (1998-2013).
BMC Infect Dis. 2015 Feb 19;15:77. doi: 10.1186/s12879-015-0826-y.
4
Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997-2007.
Med Mycol. 2010 Jun;48(4):570-9. doi: 10.3109/13693780903437876.
5
Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting.
Clin Infect Dis. 1999 Mar;28(3):629-33. doi: 10.1086/515161.
6
The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis.
Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):50-2. doi: 10.1016/s0035-9203(97)90393-x.
Zotero 插件